Diabetes – osteoarthritis and joint pain

[1]  A. Simpson,et al.  Role of microRNA in muscle regeneration and diseases related to muscle dysfunction in atrophy, cachexia, osteoporosis, and osteoarthritis , 2020, Bone & joint research.

[2]  J. Seco-Calvo,et al.  Synovial fluid peptidase activity as a biomarker for knee osteoarthritis clinical progression , 2020, Bone & joint research.

[3]  Q. Shi,et al.  Mesenchymal stem cells - a promising strategy for treating knee osteoarthritis , 2020, Bone & joint research.

[4]  F. Tian,et al.  Parathyroid hormone (1-34) ameliorates cartilage degeneration and subchondral bone deterioration in collagenase-induced osteoarthritis model in mice , 2020, Bone & joint research.

[5]  A. A. Oroojan,et al.  Type 2 Diabetes Mellitus and Osteoarthritis: the Role of Glucose Transporters , 2020, Clinical Reviews in Bone and Mineral Metabolism.

[6]  Y. Wen,et al.  Integration of transcriptome-wide association study and messenger RNA expression profile to identify genes associated with osteoarthritis , 2020, Bone & joint research.

[7]  J. Lindon,et al.  Can joint fluid metabolic profiling (or “metabonomics”) reveal biomarkers for osteoarthritis and inflammatory joint disease? , 2020, Bone & joint research.

[8]  H. Schaible,et al.  Impact of Diabetes Mellitus on Knee Osteoarthritis Pain and Physical and Mental Status: Data From the Osteoarthritis Initiative , 2020, Arthritis care & research.

[9]  G. Collins,et al.  Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 , 2019, Annals of the Rheumatic Diseases.

[10]  Richard J. Miller,et al.  The Innate Immune Response As A Mediator Of Osteoarthritis Pain. , 2019, Osteoarthritis and cartilage.

[11]  C. Cooper,et al.  Type 2 diabetes mellitus and osteoarthritis. , 2019, Seminars in arthritis and rheumatism.

[12]  Z. Zha,et al.  Expression and Significance of MMPs in Synovial Fluid, Serum and PBMC Culture Supernatant Stimulated by LPS in Osteoarthritis Patients With or Without Diabetes. , 2017, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[13]  N. Ç. Basaran,et al.  Musculoskeletal problems in diabetes mellitus , 2018, European journal of rheumatology.

[14]  H. Schaible,et al.  Mechanisms of Osteoarthritic Pain. Studies in Humans and Experimental Models , 2017, Front. Mol. Neurosci..

[15]  G. Zhai,et al.  Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes , 2017, PloS one.

[16]  H. Schaible,et al.  Pain sensation in human osteoarthritic knee joints is strongly enhanced by diabetes mellitus , 2017, Pain.

[17]  A. F. Mendes,et al.  Diabetes-accelerated experimental osteoarthritis is prevented by autophagy activation. , 2016, Osteoarthritis and cartilage.

[18]  J. Sellam,et al.  Osteoarthritis and type 2 diabetes mellitus: What are the links? , 2016, Diabetes research and clinical practice.

[19]  Daniel A. London,et al.  Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. , 2016, Journal of diabetes and its complications.

[20]  F. Berenbaum,et al.  Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. , 2015, Osteoarthritis and cartilage.

[21]  L. Nordsletten,et al.  Diabetes Is Associated With Increased Hand Pain in Erosive Hand Osteoarthritis: Data From a Population‐Based Study , 2015, Arthritis care & research.

[22]  E. Weiss.  Knee osteoarthritis, body mass index and pain: data from the Osteoarthritis Initiative. , 2014, Rheumatology.

[23]  R. Wu,et al.  Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus , 2014, Bone & joint research.

[24]  K. Tsai,et al.  Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products , 2013, PloS one.

[25]  A. Iagnocco,et al.  Diabetes Is an Independent Predictor for Severe Osteoarthritis , 2013, Diabetes Care.

[26]  Paul J Thornalley,et al.  Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy , 2012, Nature Medicine.

[27]  F. Berenbaum.  Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype , 2011, Annals of the rheumatic diseases.

[28]  A. F. Mendes,et al.  Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage , 2009, Arthritis research & therapy.

[29]  H. Schaible,et al.  Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. , 2007, Arthritis and rheumatism.